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Abstract
Background: A gap exists in our mechanistic understanding of how genetic and environmental risk factors
converge at the molecular level to result in the emergence of autism symptoms. We compared blood-based gene
expression signatures in identical twins concordant and discordant for autism spectrum condition (ASC) to
differentiate genetic and environmentally driven transcription differences, and establish convergent evidence for
biological mechanisms involved in ASC.
Methods: Genome-wide gene expression data were generated using RNA-seq on whole blood samples taken from
16 pairs of monozygotic (MZ) twins and seven twin pair members (39 individuals in total), who had been assessed
for ASC and autism traits at age 12. Differential expression (DE) analyses were performed between (a) affected and
unaffected subjects (N = 36) and (b) within discordant ASC MZ twin pairs (total N = 11) to identify environmental-driven
DE. Gene set enrichment and pathway testing was performed on DE gene lists. Finally, an integrative analysis using
DNA methylation data aimed to identify genes with consistent evidence for altered regulation in cis.
Results: In the discordant twin analysis, three genes showed evidence for DE at FDR < 10%: IGHG4, EVI2A and
SNORD15B. In the case-control analysis, four DE genes were identified at FDR < 10% including IGHG4, PRR13P5,
DEPDC1B, and ZNF501. We find enrichment for DE of genes curated in the SFARI human gene database. Pathways
showing evidence of enrichment included those related to immune cell signalling and immune response,
transcriptional control and cell cycle/proliferation. Integrative methylomic and transcriptomic analysis identified a
number of genes showing suggestive evidence for cis dysregulation.
Limitations: Identical twins stably discordant for ASC are rare, and as such the sample size was limited and constrained
to the use of peripheral blood tissue for transcriptomic and methylomic profiling. Given these primary limitations, we
focused on transcript-level analysis.
Conclusions: Using a cohort of ASC discordant and concordant MZ twins, we add to the growing body of
transcriptomic-based evidence for an immune-based component in the molecular aetiology of ASC. Whilst the sample
size was limited, the study demonstrates the utility of the discordant MZ twin design combined with multi-omics
integration for maximising the potential to identify disease-associated molecular signals.
Keywords: Autism spectrum disorder, Immune, MZ twins, RNA-seq, Gene expression, DNA methylation,
Transcriptomics, Epigenomics, Discordance
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Background
Autism spectrum condition (ASC) is a neurodevelopmen-
tal disorder typified by deficits in social communication
and by stereotyped behaviours. Twin, family and DNA-
based studies consistently indicate a strong genetic basis
for the disorder, with both common and rare variants con-
tributing to overall risk [1–6]. While a significant propor-
tion of genetic liability for ASC can now be captured by
polygenic profile scores derived from large-scale genome-
wide association studies [1, 7], there exists a gap in our
ability to build mechanistic models of how genetic and
non-genetic risk factors influence early brain development
and result in autism symptoms. Complementary func-
tional genomic approaches that profile gene expression
and epigenetic regulation could prove valuable in this re-
gard. Because these intermediate molecular traits lie be-
tween genotype and phenotype, they can be informative
about underlying mechanisms even when the trait is
multifactorial and highly genetically heterogeneous, by
providing evidence of convergence of risk on common
downstream pathways [8]. In addition, gene regulatory
and expression signatures may also have utility as bio-
markers [9] as they can display individual level variability
that is not completely heritable [10–12], may persist long
after the initial exposure [13] and may be detectable in tis-
sues other than those primarily affected [14, 15].
A number of studies have characterised global gene ex-
pression in ASC, typically using microarrays and whole
blood or blood-derived cells. A recent mega-analysis of
seven primary blood-based microarray datasets extended
previous array-based meta-analyses [16, 17] and found
support for reduced-expression of transcripts relating to
innate and adaptive immunity [18]. Brain-based transcrip-
tomic investigations of ASC using arrays are scarcer and
generally limited to examination of post-mortem brain re-
gions across a wide age range [19, 20], some of which have
recently been meta-analysed to populate a searchable dif-
ferential gene expression database for ASC [21].
More recently, gene expression studies have utilised
RNA-seq as it can interrogate gene expression in much
greater resolution than expression arrays, including low
abundance transcripts as well as alternatively spliced,
and non-coding regulatory transcripts [22]. RNA-seq has
been used to characterise genome-wide patterns of ex-
pression for a range of neurodevelopmental and psychi-
atric conditions including major depressive disorder
(MDD) [23], schizophrenia [24], bipolar disorder [25]
and Alzheimer’s disease [26]. RNA-seq has also been
used to investigate gene expression in a developmental
context in healthy controls [27], and also in ASC-
affected individuals [19, 28]. The largest published aut-
ism RNA-seq study of post-mortem brain tissue found
evidence for cortex-specific differential gene expression
and alternative splicing events, with enrichment for
genes expressed in microglia and astrocytes [29]. A sec-
ond (smaller) study identified an ASC-associated gene
co-expression module that was enriched for microglia
cell states and type 1 interferon pathway, and the au-
thors hypothesised a putative link between neuronal
activity-dependent gene regulation mediated by innate
immune response [28].
To date, the majority of gene expression studies of
ASC have utilised case-control designs that are limited
in their capacity to investigate the influence of environ-
mental factors, due to the potential for genetic and other
sources of confounding. Intermediate molecular traits
such as DNA methylation and transcription can be influ-
enced by genetic variation (i.e. mQTLs and eQTLs), in
addition to displaying environmentally linked and sto-
chastic variability, complicating attempts to separate
genetically driven from environmentally driven effects
(and their interactions) [10]. To overcome some of these
challenges, a number of authors have recommended a
discordant identical twin-based design [30, 31]. Because
identical (monozygotic; MZ) twins are matched for age,
sex, genetic background, as well as family-wide factors
[32], divergence in gene expression patterns or epigen-
etic marks can indicate causes or consequences of dis-
ease that are independent of genetic effects [33]. In ASC,
despite the high heritability, MZ concordance rates do
not rise above 90% [34], suggesting a role for non-shared
effects such as epigenetic, gene expression, other envir-
onmental and/or stochastic factors [35, 36]. Epidemio-
logical investigation of what these specific non-shared
environmental factors might be is difficult, especially
given that the relevant exposures are likely to occur early
in development. Investigation of the intermediate mo-
lecular phenotype of gene expression might therefore act
as a useful proxy for relevant non-shared environmental
effects as it is tangibly linked to underlying cellular pro-
cesses and can reflect the aggregate effects of environ-
mental influences that could persist long after the initial
exposure. Identification of environmentally attributable
differential gene expression would provide critical in-
sights into the mechanistic developmental origins of
ASD, as well as provide a potential biomarker for diag-
nostics, treatment assessment or intervention studies.
Genome-wide gene expression profiling of discordant
MZ twins has previously been performed for a range of
cognitive, physical, psychiatric and neurological traits in-
cluding BMI [37, 38], intelligence [39], bipolar disorder
[40] and Alzheimer’s disease [41]. There has however
been limited application of this methodology to ASC. A
study by Hu et al. examined gene expression in three
pairs of MZ ASC discordant and two pairs of MZ ASC
concordant twins and identified expression differences
in gene networks involved in neurological function, ner-
vous system development and inflammation [42]. Several
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studies have successfully utilised MZ twins to investigate
altered DNA methylation in psychiatric traits [43–46].
We previously performed genome-wide DNA methyla-
tion profiling in the cohort used in the current study
that included ASC discordant, ASC concordant, as well
as unaffected concordant MZ twin pairs, which investi-
gated differences within discordant pairs and between
groups (cases and controls) [47]. While ASC was not as-
sociated with global changes in DNA methylation
within-discordant pairs, a number of CpG sites were
found to be differentially methylated between co-twins,
with the top association a CpG site located in the pro-
moter of the NFYC gene.
As far as we are aware, there are no previous studies
that have utilised a MZ differences twin design to char-
acterise genome-wide gene expression and DNA methy-
lation differences in the same individuals. Here, we
conduct a genome-wide gene expression study using
RNA-seq to profile global patterns of gene expression in
subjects from a cohort of ASC discordant, ASC concord-
ant and unaffected concordant control MZ twin pairs
for whom we have previously characterised DNA methy-
lation [47]. Genome-wide gene expression profiles were
generated and two main analyses carried out. Firstly, we
performed within-group analysis of the discordant ASC
twins with the aim to identify genes and pathways show-
ing altered expression in common in ASC compared to
non-ASC co-twins, attributable to non-shared environ-
mental factors. Secondly, we performed a case-control
analysis by comparing ASC affected from both
discordant and concordant groups with unaffected, age-
matched controls to identify genes and pathways com-
monly disrupted in ASC, which could be attributable to
both genetic and/or environmental factors. Finally, we
performed data integration with previously published
methylation array data to determine if identified gene
expression signatures showed any relation to previously
identified DNA methylation signatures, and whether
such an integrative analysis could lend further support
to identified pathways and mechanisms.
Methods
Subjects
Subjects were originally recruited as part of the Twins
Early Development Study (TEDS; https://www.teds.ac.uk/),
a longitudinal study investigating the cognitive and behav-
ioural development of twins born in England and Wales
between January 1994 and December 1996 [48–50]. TEDS
participants completed various web and telephone-based
tests and questionnaires at regular intervals over childhood
and adolescence designed to assess various aspects of
cognition, language and behaviour (see [50] for further de-
tails). Twins were assessed for ASC-related traits and
behaviours at ages 8 and 12 using the Childhood Autism
Spectrum Test (CAST). The CAST is a 31-item question-
naire that assesses ASC traits [51, 52]. The 31 items are
combined additively to give a total CAST score out of 31,
with those scoring ≥ 15 categorised as “at risk” of having
an ASC. Individuals identified as at risk were also formally
assessed at home using the Autism Diagnostic Interview-
Revised (ADIR) [53] and the Autism Diagnostic Observa-
tion Schedule (ADOS) [54] both considered gold standard
diagnostic tools. Twins were selected from the TEDS sam-
ple of ~ 10,000 twin pairs based on scores on the CAST
total score or whether a clinical diagnosis of ASC had been
made, and assigned to three study groups: concordant
ASC (MZ pairs where both members of the twin pair had
a formal ASC diagnosis; 28 pairs identified, of which 25
male), discordant ASC (MZ pairs where one member of
the twin pair had formal ASC diagnosis; 14 pairs identified,
11 male) and low total CAST controls (unaffected MZ
pairs where both twins scored less than or equal to the
sample mean in total CAST score (≤ 6); 120 pairs identi-
fied, of which 45 were male). We additionally required that
the concordant MZ twin pairs with low ASC symptoms
had birth weights within 1 SD of each other, had no re-
ported medical conditions and were not perinatal outliers.
All samples were of white ethic origin. Identified families
were contacted and invited to participate in the study,
which resulted in a total of 23 MZ twin pairs visiting the
SGDP lab to have whole blood samples collected by a
trained phlebotomist: six concordant ASC, six discordant
ASC and 11 control pairs (total N = 46). Blood samples
were successfully obtained for 40 individuals: ten concord-
ant ASC (four pairs, two individual members of a twin
pair), 11 discordant ASC (five pairs, one individual), 19
concordant low total CAST (unaffected controls) (eight
pairs, three individuals).
RNA isolation, library preparation and sequencing
Whole blood samples were collected and stored using
the PAXgene system (PreAnalytiX QIAGEN, Germany).
Total RNA was extracted (5 μg for each sample) and the
Ribo-Zero Globin kit (Ambion, USA) was used to de-
plete ribosomal and globin RNAs. Sample concentration
and quality was assessed using the RNA 6000 Nano Lab-
Chip and Agilent 2100 BioAnalyzer systems (Agilent
Technologies, USA). The majority of samples (36/40)
had RNA integrity (RIN) values between 7 and 9
(mean = 8.2). The four remaining samples had RIN
values < 7 (mean = 4.8), with one sample from the con-
cordant ASC group found to be severely degraded
(RIN = 2.6) which was subsequently excluded from fur-
ther analysis (see Fig. 1). Stranded total RNA libraries
were prepared for the remaining 39 samples using the
Illumina TruSeq Stranded Total RNA Library Prep Kit
v3 (Illumina, USA) following the manufacturer’s proto-
col for a low-throughput experiment. The final libraries
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consisted of indexed fragments with median length
326 bp (160 bp inserts). The Agilent BioAnalser system
was used to assess the fragment length distribution. The
libraries were then pooled and randomised across the
lanes of a single flow cell of the Illumina HiSeq 2000
(Illumina, USA) sequencing in 100-bp paired end mode.
Sample libraries were randomised across lanes in an ap-
proximation of a balanced design (to the extent that was
possible with the starting sample characteristics), with
twin pairs split across the lanes and each lane containing
subjects from each of the three study groups (discordant
ASC, concordant ASC and concordant controls). To en-
sure each lane had the same number of samples and
read density, one sample from the concordant ASC
group was run in duplicate, so that in total RNA libraries
for 40 samples were sequenced (for 39 individuals). The
resulting reads were demultiplexed by filtering according
to the 6 bp index sequences contained within the adap-
tors and unique to each sample.
Data preprocessing, mapping and quantification
The fastq files containing the sequenced reads for each
sample were downloaded and initial data preprocessing
and quality control were carried out. The FastQC pro-
gram (v0.11.2) [55] was used to produce general sequen-
cing metrics. The number of reads per library ranged
between 38 and 78 M, with a mean of approximately
54 M reads per sample. Plots for per-base sequence
quality, per-sequence quality, sequence length distribu-
tion, GC content were inspected, and found to be as ex-
pected for all samples. The average sequence duplication
rate for each library was around 0.21, also in line with
expectations [56]. Next, to improve mapping efficiency,
the cutadapt tool (v1.4.1, [57]) was used to trim lower
quality base pair calls from the ends of sequences, and
to remove any reads mapping to Illumina adaptor
sequences.
Reads were mapped to the Ensembl hg19 reference
genome using Tophat2 (v2.0.12) [58]. To assess the ef-
fectiveness of read mapping and the quality of the
alignments, RNA-SeQC (v1.1.8) [59] was used to pro-
duce summary statistics including total proportion of
mapped reads, proportion of reads mapping in pairs,
the effectiveness of the stranded protocol, fraction of
reads mapping to exonic or intronic regions and cover-
age along the length of the transcripts. These metrics
were compared to guidelines from GEUVADIS [56].
The overall indications were that the sequencing data
generated was of a high quality, with on average 78% of
total reads mapping in their forward and reverse read
pairs, 47% of these reads originating from exonic re-
gions, a mean coverage of 6× for less abundant tran-
scripts (bottom 1000) and 732× for transcripts present
at higher levels (top 1000).
The featureCounts program [60] from the subread
package (v1.4.6) [61] was next used to summarise and
quantify the mapped reads, by counting the number of
reads overlapping Ensembl gene annotations. Finally,
filtering was performed to remove genes with low
counts with required counts of ≥ 1 CPM (counts per
million) in at least three samples leaving count data for
17,765 genes.
Fig. 1 Study group sample characteristics (N = 39)
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Post quantification QC
Following quantification, a number of QC steps were per-
formed to assess the quality of the final gene expression
profiles and identify any outliers. Firstly, concordance be-
tween expression profiles within the twin pairs was exam-
ined. As gene expression is at least partially heritable
(mean h2 ~ 0.14 to 0.3) [11, 62], twins would be expected
to show higher correlation in gene expression profiles
than in comparison to unrelated subjects. To confirm this,
counts were normalised by total library size and trans-
formed into logCPM (log counts per million), and Pear-
son’s correlation was calculated. A heatmap was produced
to visualise the results, and mean correlation values within
pairs and between unrelated subjects were recorded. Next,
clustering and data reduction techniques were used to
produce visualisations for examining the similarity of the
expression profiles and determine if any clustering by
technical or biological factors was observed, specifically by
case status, study group, sex or flow cell lane. Firstly, hier-
archical, unsupervised clustering was performed with the
hclust function in R using Euclidean distance between
samples based on gene expression profiles. These were
plotted as dendrograms (Additional file 1: Figure S1).
Multi-dimensional scaling (MDS) plots were also gener-
ated for further visualisation of sample similarity based on
leading log fold changes between pairs of samples
(Additional file 1: Figure S2).
Differential gene expression
The edgeR package [63] was used to perform differential
expression (DE) analyses. This uses a generalised linear
modelling (GLM) strategy to model systematic and bio-
logical sources of variation, and an empirical Bayes
method to improve estimates by shrinking gene-wise dis-
persions towards the common trend. Following the stand-
ard edgeR workflow, count data was normalised for total
library size, using trimmed mean of M values (TMM),
which minimises log FCs between samples for the major-
ity of genes. To test for differential expression attributable
to ASC case status, for each gene a negative binomial
GLM model was used and a likelihood ratio test (LRT)
performed. Multiple testing was controlled at FDR 10%,
chosen due to the discovery nature of the study.
Two primary DE analyses were performed. Firstly, a
within group analysis of the ASC discordant twins was
performed to identify differences in gene expression asso-
ciated with ASC which could be attributable to non-
shared environment. This analysis will be referred to as
“discordant group” from this point. The model used speci-
fied gene count as the outcome which was regressed on
pair—a categorical variable representing twin-pair mem-
bership, and case—a binary variable denoting case status.
The results were further annotated to indicate whether
the direction of effect (log FC) was consistent across pairs.
For the second analysis, cases and controls from across
the complete sample were compared to identify gene ex-
pression differences associated with ASC that could be
genetic and/or environmental in origin. We refer to this
analysis and the results as “case-control” from here on.
The model used was the same as used in the discordant
twin analysis above, with gene count the outcome and pair
and case status the explanatory variables.
Finally, within-pair gene expression differences were
assessed to determine whether these showed consistent
differences in magnitude or overall distribution between
the three study groups. For each pair separate, edgeR
models were fit (comparing one co-twin to the other).
Then for each of the study groups, absolute logFCs across
all genes and pairs were recorded, and scatter plots
produced. Both t tests and Kolmogorov–Smirnov (KS)
tests were performed comparing the means and overall
distributions for each group (Additional file 1: Figure S5).
Gene set enrichment and pathways
Gene set enrichment testing was performed to investi-
gate whether identified differential expression signals in-
volved known ASC risk genes. The geneSetTest method
from limma [64] was used with ranks only, comparing
the mean rank of the set of interest with permuted sets.
Three different ASC genesets were tested for enrich-
ment. The first of these was from the Simons Founda-
tion Autism Research Initiative (SFARI) gene resource
[65, 66], a manually curated reference database of ASC
genes from published molecular studies including candi-
date genes, known common and rare variants and copy
number variants linked to ASC. These are divided into
different categories based on the strength of evidence.
We combined these into two gene sets: category 1 and 2
(high confidence and strong candidate) (n = 91), and
categories 3, 4 and 5 (suggestive evidence, minimal evi-
dence and hypothesised) (n = 842). The second gene set
was derived from the association results of the iPSYCH-
PGC ASD GWAS meta-analysis of over 18,381 individ-
uals with ASD [67], setting a p value threshold of 1 ×
10−6 and taking the set of genes that these mapped to
(according to Ensembl hg19 annotation) (n = 28). Finally,
we used the TADA set of genes from an exome sequen-
cing study of 2270 trios, which identified genes showing
evidence for increased burden of de-novo loss of
function in autistic subjects (n = 107) [2]. All sets were
accessed and downloaded in July 2019.
Pathway enrichment analyses were carried out to iden-
tify biological pathways and cellular processes over-
represented within the differentially expressed genes.
The ROMER method from limma was used. Pathway
datasets were from the Molecular Signatures Database
(MSigDB) [68], comprising biochemical pathways (from
Kyoto Encyclopedia of Genes and Genomes—KEGG
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[69] and REACTOME [70]), gene families (from Gene
Ontology—GO [71]) and various other sources of anno-
tation. Two sets were used, the C2 curated set—contain-
ing 4726 canonical metabolic and signalling pathways,
and disease gene expression signatures, and the H1
hallmark set—50 gene sets representing well-defined
biological states or processes where genes show coordi-
nated expression.
Integration with DNA methylation data
Using an existing Illumina 27 K DNA methylation data-
set generated on the same sample [47], an integrative
analysis was performed to derive further insights into
the functional relevance of DE genes and identify genes
with consistent evidence for altered regulation in ASC,
representing putative disorder associated cis expression
quantitative trait methylation loci (eQTMs). The stored
Beta values were first converted to M values as these
have distributional properties more suitable for use in
standard linear regression [72], and differential methyla-
tion analysis performed. The ComBat function from the
SVA package [73] was used to identify batch and other
unmeasured sources of variation—in this case, none
were identified. Next, edgeR [74] was used to fit a linear
model for discordant group and case-control compari-
sons, using the same models described above for the
RNA-seq data. Given the limited of coverage of the
array, a simple gene-level integration strategy was
followed looking for evidence of cis regulatory signals
across the datasets. Firstly, to assess the level of
concordance, Spearman’s correlation coefficient was cal-
culated between gene-level expression (as normalised
counts per million) and gene-level DNA methylation
(aggregating CpG probes and taking the median Beta
value as representative). Secondly, evidence combination
was performed. The SLK method from comb-p [75] was
used to obtain spatial correlation adjusted p values for
each CpG site, setting the distance parameter to 2000 bp
and region filter to 0.05. These were summarised at the
gene level by taking the minimum p value. This was then
combined with the gene level statistics from the RNA-
seq results using empirical Brown’s method [76], which
takes into account correlation between measures (using
the assay data), to derive a combined p value for genes
measured in both assays. The final list of genes was then
sorted by combined p value and the top 20 retained.
Male subgroup analysis
Previous studies have identified sex-specific patterns of
gene expression associated with ASC [77, 78], with the lat-
ter also demonstrating that separate analyses of males and
females improved the ability to detect ASC-related differ-
ences. Here, because the sample contained only two af-
fected females (both discordant group), we were not
adequately powered to perform a sex-stratified analysis.
Instead, the main analyses were rerun using male subjects
as an explicit control for sex, which in the main analysis
was presumed to have been captured by pair status (as a
nested effect—since MZ twins are the same sex).
QQ plots were generated and inspected (data not shown)
to compare the models in terms of overall distribution of p
values. The lists of top differentially expressed genes were
also compared to evaluate the impact of excluding female
samples on the ranks of FDR significant DE genes and
whether this improved our ability to detect ASC-related dif-
ferences. See Additional file 1: Table S13 and S14.
Blood cell composition and surrogate variable analysis
Issues related to cellular heterogeneity have received much
attention in the transcriptomics [79–83] and epigenomics
literature [84–88]. Cell composition can act as a con-
founder, or alternatively represent a variable of interest if
disease-associated changes in cell populations or cell
subtype-specific expression patterns are disease relevant. In
the context of this study, it was not clear how cellular het-
erogeneity should be dealt with since changes in cell com-
position could well be ASC relevant, with previous studies
finding evidence for increased numbers of activated B and
NK cells in ASC affected individuals [89, 90]. As full blood
cell counts for our samples were not available, we per-
formed cell subtype estimation as a post hoc analysis, to de-
termine whether the main findings were likely being driven
by differences in blood cell composition. The XCell soft-
ware was used to infer cell counts, which compares the ex-
perimental RNA-seq data to expression signatures
spanning 64 immune and stromal cell types and calculates
an enrichment score [83]. Blood cell adjustment was per-
formed as part of surrogate variable analysis.
Surrogate variable analysis (SVA) [73] was performed
firstly to identify any unmodelled technical variation and
secondly to reduce the number of parameters required
to model inferred blood cell counts—since these could
be much greater than the sample size. The two main
analyses and the male-only versions were re-run using
models including surrogate variable adjustment. Correl-
ation between identified SVs and cell counts were calcu-
lated to determine if these were likely to be accounting
for these variables. As before, QQ plots (not shown) and
relevant summary statistics were generated and
inspected to compare the different models, and the
ranks of DE genes at FDR 20% between models com-
pared (see Additional file 1: Table S13 and S14).
Results
Exploratory analysis
Exploratory analysis was performed to assess the quality
of the gene expression profiles generated. Gene expression
profiles were compared between individuals; high within-
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twin correlations were observed (median = 0.98), greater
than those observed for unrelated individuals (median =
0.96) (Fig. 2), as expected. Next, sample clustering was
performed (Additional file 1: Figure S1a,b). The dendro-
grams showed male and female subjects segregating into
two distinct clusters with no sex outliers, and 15 (of the
16) complete twin pairs clustering together in nodes.
MDS plots for the first six dimensions were inspected,
which showed that samples mainly clustered by sex, case
and experimental group, whereas sequencing lane was not
seen to segregate the data (Additional file 1: Figure S2).
Inspection of these plots also revealed the presence of
three outliers, which were subsequently removed from
further analysis. Following these steps, 36 samples were
taken forward for differential expression analysis
(Additional file 1: Table S1a,b and S2a,b).
Differential expression analysis
The DE genes identified in the within discordant pairs
analysis are presented in Table 1 (with extended list in
Additional file 1: Table S3). The volcano plot is shown in
Fig. 3a, and examination of the QQ plots is suggestive of
uncorrected biases, although we were unable to identify
any single factor (see Additional file 1: Figures S3a and
S4a). Overall, three genes pass FDR 10%: IGHG4 (logFC =
2.15, FDR = 0.0004), EVI2A (logFC = − 0.66, FDR = 0.02)
and SNORD15B (logFC = − 0.85, FDR = 0.02). Further
down the list of suggestive genes at FDR 20%, a number of
ribosomal genes are identified (RPL9, RPL30, RPL41,
RPS3A). The majority of the top ranked genes were found
to have a consistent direction of effect across all discord-
ant pairs (ten out of 16 genes at FDR < 20%), which were
all in the direction of decreased expression in ASC af-
fected compared to unaffected co-twins. Additional file 1:
Figure S6 shows the expression levels for DE genes at
FDR < 10% for each of the twin pairs, stratified by ASC af-
fected status. The direction of the effect is largely consist-
ent for all three genes, with IGHG4 showing mainly
increased expression in ASC cases compared to unaffected
co-twin (for four out of five pairs), and EVI2A and
SNORD15B showing decreased expression in all affected
twin pair members.
Fig. 2 Heatmap showing individuals clustered using correlation of genome-wide expression values between samples as distance (also shown as
dendrograms). High correlation r values of 0.99 and above are indicated by the dark coloured squares along the diagonal. Twin pairs are found to
have an average correlation of 0.98, compared to 0.96 for unrelated subjects. cASC concordant ASC, dASC discordant ASC, cltC concordant low
total CAST (control)
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The DE genes from the case-control analysis are pre-
sented in Table 2 (extended results in Additional file 1:
Table S4), and the volcano plot is shown in Fig. 3b
(further plots provided in S3b and S4b). Four genes pass
FDR 10%: IGHG4 (logFC = 2.04, FDR = 0.10), PRR13P5
(logFC = 1.53, FDR = 0.10), DEPDC1B (logFC = − 1.32,
FDR = 0.10) and ZNF501 (logFC = − 0.88, FDR = 0.10),
all four of which were also highly ranked in the discord-
ant pairs analysis. Annotation of the 19 genes identified
as nominally differentially expressed (FDR < 20%) across
the discordant twin and case-control analyses revealed
two non-coding RNAs (SNORD15B and AL662889.1),
and suggested a bias towards RNA binding activity. See
Additional file 1: Table S5.
Within-pair comparisons
To assess whether within-pair expression differences
varied between discordant ASC, concordant ASC and
concordant low total CAST twins, the distributions of
within-pair log FCs were compared (Additional file 1:
Fig. 3 a, b Volcano plots showing relationship between significance and logFC for a discordant and b case control analyses. DE genes passing
FDR < 0.1 are indicated by the coloured points and labelled
Table 1 Discordant group differentially expressed genes at FDR < 20%. For each gene, the estimated fold change, average
expression (in log counts per million), p value and FDR adjusted p values from edgeR are given. The final column indicates if the
gene showed a consistent direction of differential expression across all twin pairs and the arrow which direction this was in
(increased or decreased expression in ASC affected compared to unaffected co-twin)
ensembl gene id hgnc symbol chr logFC logCPM P value FDR cons. dir
ENSG00000211892 IGHG4 14 2.1483 1.9484 2.11E-08 3.76E-04
ENSG00000126860 EVI2A 17 − 0.6581 5.1208 2.88E-06 1.94E-02 ↓
ENSG00000207445 SNORD15B 11 − 0.8524 3.0638 3.28E-06 1.94E-02 ↓
ENSG00000150681 RGS18 1 − 0.5252 6.9877 2.49E-05 1.11E-01 ↓
ENSG00000139679 LPAR6 13 − 0.6090 4.7990 3.46E-05 1.23E-01 ↓
ENSG00000163682 RPL9 4 − 0.6645 6.8391 5.01E-05 1.48E-01
ENSG00000163736 PPBP 4 − 0.4830 7.4291 6.32E-05 1.60E-01 ↓
ENSG00000035499 DEPDC1B 5 − 1.3113 0.5493 1.00E-04 1.86E-01 ↓
ENSG00000187534 PRR13P5 19 1.5220 0.4947 1.14E-04 1.86E-01
ENSG00000198339 HIST1H4I 6 − 0.6694 3.7498 1.15E-04 1.86E-01 ↓
ENSG00000156482 RPL30 8 − 0.5020 8.3615 1.18E-04 1.86E-01 ↓
ENSG00000229117 RPL41 12 − 0.5682 6.9233 1.28E-04 1.86E-01 ↓
ENSG00000166710 B2M 15 − 0.5655 11.3125 1.44E-04 1.86E-01 ↓
ENSG00000138180 CEP55 10 − 1.4366 0.2429 1.48E-04 1.86E-01
ENSG00000184825 HIST1H2AH 6 − 0.7410 3.6227 1.61E-04 1.86E-01
ENSG00000145425 RPS3A 4 − 0.7436 6.8823 1.67E-04 1.86E-01
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Figure S5). The mean log FCs differed by group: discord-
ant ASC = 0.44, concordant ASC = 0.39, low total
CAST = 0.39 and t tests showed this difference was sig-
nificant when comparing discordant ASC to concordant
ASC (p < 2.2 × 10−16) and discordant ASC to concordant
low total CAST (p < 2.2 × 10−16). The cumulative distri-
butions of the log FCs also differed by group, with KS
tests indicating a significant difference between discord-
ant ASC and concordant low total CAST (p < 2.2 ×
10−16), discordant ASC and concordant ASC (8.3 ×
10−14) and concordant ASC and concordant low total
CAST (p < 2.2 × 10−16). Additional file 1: Figure S7
shows distributions of the expression levels for all four
DE genes identified at FDR < 10% in the case-control
comparison, stratified by study group and case status.
The distribution of expression values can be seen to vary
depending on study group, with differences between af-
fected and unaffected co-twins in the discordant ASC
appearing on visual inspection to be greater than differ-
ences between concordant ASC twin pairs, and concord-
ant low total CAST twin pairs.
Gene set testing
ASC-associated genes
Focused testing of a number of ASC-associated genesets
was performed to test for possible enrichment of previ-
ously identified ASC-risk genes. The results are pre-
sented in Additional file 1: Table S6. There is evidence
for enrichment of ASC-associated genes from the SFARI
gene set in gene score categories 1 and 2, and categories
3, 4 and 5 in both the discordant and case-control DE
gene lists. The iPSYCH-PGC and TADA genesets do
not show enrichment in either of the DE gene lists.
Pathways
The lists of DE genes from both analyses were tested for
enrichment of MSigDB pathways. The results are pre-
sented in Additional file 1: Tables S7–S10. For the dis-
cordant analysis, a number of potentially relevant
pathways (unadjusted p < 0.05) were identified including
those involved in cell signal integration (mTORC1 signal-
ling), regulation of gene expression (MYC targets, E2F
targets), immune response (Bohn primary immunodefi-
ciency syndrome) and genomic stability (chromosome
maintenance). For the case-control analysis, regulation of
gene expression (E2F targets, MYC targets), cell signal in-
tegration (mTORC1 signalling, PI3K AKT mTOR signal-
ling) and immune response pathways were similarly
identified (Browne HCMV infection, Bohn primary im-
munodeficiency syndrome).
Integration with DNA methylation data
The gene expression data was integrated with DNA
methylation data on the same individuals. The top 20 re-
sults are given in Additional file 1: Tables S11 and S12. In
the discordant analysis, a number of genes show some
combined evidence for differential expression and methy-
lation which is consistent with the findings from DE and
pathways analysis implicating immune signalling—DAPP1,
and regulation of expression/translation: ZNF501, EIF5A2,
HIST1H2AG. In the case-control results, ZNF501, DAPP1
and EIF5A2 were also highly ranked.
Post hoc sensitivity analyses
Sensitivity analyses were performed, including a male-
only analysis and a surrogate variable-based modelling
approach intended to capture blood cell composition
and other unmeasured batch effects. The identified DE
genes were found to be largely robust to the inclusion of
surrogate variables in the model, and were not influ-
enced by the exclusion of female samples in the male
subjects only analysis (see Additional file 1: Tables S13
and Table S14). In the discordant analysis, the top 3
identified DE genes IGHG4, EVI2A and SNORD15B
were consistently found to be within the top 0.03% (rank
≤ 5) to ~ 3% (rank ≤ 600) of DE genes for SV adjusted
and male-only analysis. For the case-control analysis,
similarly IGHG4, DEPDC1B and ZNF501 were also con-
sistently within the top ~ 3%.
Discussion
Differential expression
We performed gene expression profiling by RNA-seq in
identical twins discordant for ASC. The overall findings
are consistent with the hypothesis that gene expression
differences in discordant twins could contribute to (or
are a consequence of) phenotypic differences, and we
further identify specific gene expression differences
Table 2 Case-control differentially expressed genes at FDR < 20%
Ensembl gene id HGNC symbol Chr logFC logCPM P value FDR
ENSG00000211892 IGHG4 14 2.0362 1.0333 8.06E-06 9.73E-02
ENSG00000187534 PRR13P5 19 1.5312 0.3223 1.27E-05 9.73E-02
ENSG00000035499 DEPDC1B 5 − 1.3208 0.4996 1.65E-05 9.73E-02
ENSG00000186446 ZNF501 3 − 0.8795 2.1953 2.19E-05 9.73E-02
ENSG00000224442 2 0.6384 2.9985 4.53E-05 1.61E-01
ENSG00000232184 1 1.0939 1.0182 5.76E-05 1.71E-01
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associated with ASC affected status. In the discordant
group analysis comparing gene expression in ASC af-
fected compared to unaffected co-twins, three DE genes
were identified at FDR < 10%: IGHG4, EVI2A and
SNORD15B. The case control analysis examining expres-
sion differences between ASC affected and control sam-
ples identified four DE genes at FDR < 10% including
IGHG4, DEPDC1B and ZNF501. Comparison of mean
within-pair logFC expression differences revealed that
differences were greater in the discordant ASC pairs
than in concordant ASC and control pairs. Inspection of
expression levels for FDR significant genes identified in
the case control analysis suggests that larger differences
in expression for trait-associated genes are apparent in
the discordant ASC pairs.
The top ranked and most highly significant DE gene in
both discordant group and case control analyses was
IGHG4—Immunoglobulin heavy constant gamma 4,
which in both analyses showed evidence for upregulation
in ASC affected compared to unaffected individuals
(discordant: logFC = 2.15, FDR = 0.0004, case control:
logFC = 2.04, FDR = 0.0973). This gene codes for an
immunoglobin (or antibody) membrane-bound protein
produced by B lymphocytes that recognises specific anti-
gens, and upon binding results in immune cell activa-
tion. While IGHG4 does not appear to have previously
been linked to ASC, interestingly two previous expres-
sion studies using whole blood identified another related
and potentially closely interacting immunoglobin IGHG1
as being upregulated [91, 92] and in one study downreg-
ulated [42] in ASC. The existing evidence for the associ-
ation of IGHG1 with ASC, together with the observation
that immune-related genes and pathways are some of
the most common and highly replicated findings in ASC
gene expression studies (discussed further below), lends
further support to our identification of IGHG4 as an
ASC-associated DE gene.
DEPDC1B was the second ranked coding gene in the
case-control analysis (logFC = 1.32, FDR = 0.0973). This
showed suggestive evidence for association in the discord-
ant analysis (logFC = − 1.3, FDR = 0.186), but is also note-
worthy as it showed consistent effect directionality, being
downregulated in ASC affected compared to unaffected
for all discordant twin pairs. This gene is a member of the
DEP domain coding family, and is involved in intracellular
signal transduction and cell growth regulation. While it
has not previously been associated with ASC, variants in
DEPDC1B have been associated with intelligence and
general cognitive ability in two recent large-scale GWA
studies [93, 94]. The evidence taken together suggests that
DEPDC1B could be an interesting and potentially relevant
signal for further follow up study.
Focused testing of ASC-associated gene sets of interest
indicated that overall there was enrichment of previously
identified ASC loci from SFARI, whilst the iPSYCH-
PGC or TADA sets did not show evidence for enrich-
ment. These findings are consistent with those from pre-
vious studies that have tested for overlap between
established ASC risk loci and ASC DE genes. In a gene
mega-analysis of blood-based transcriptomic studies of
ASC by Tylee et al. including 626 affected and 447 com-
parison subjects, the top identified DE genes were not
found to be enriched for ASC GWAS associations [18].
Whilst the lack of enrichment for ASC-associated com-
mon genetic variants in differentially expressed gene lists
might seem surprising, the accumulated evidence would
seem to suggest that genetic association and functional
approaches are revealing distinct dimensions to the dis-
order. ASC is frequently characterised as a disorder of
the synapse based on genetic findings, whilst in contrast
functional findings often implicate other pathways
including immune system, inflammation and transcrip-
tional control [95].
Pathway analysis using collections of genes from
MSigDB revealed a number of potentially relevant path-
ways in common between both discordant and case-
control analyses. Pathways were identified implicating
the immune system (immune cell signalling/signal inte-
gration: mTORC1, immune response: Browne HCMV
infection, Bohn primary immunodeficiency syndrome),
transcriptional control (MYC targets, E2F targets) and
chromosome/genomic stability (DNA repair, chromo-
some maintenance). In support of these findings, a
recent comprehensive review of both blood and brain-
based transcriptomic studies found that immune system
pathways were among the most frequently identified
[95]. More specifically, we found replication for the ma-
jority of the top pathways: E2F targets, mTOR and MYC
pathways identified in a large mega-analysis based on
gene expression in blood [18], and immunodeficiency in
a meta-analysis using multiple tissues [16].
The integrative analysis revealed a number of genes
showing combined evidence for dysregulation in both dis-
cordant and case control comparisons that together with
the findings from the differential expression and pathways
analyses suggest involvement of immune signalling and
transcriptional regulation. We highlight DAPP1 (dual
adaptor of phosphotyrosine and 3-phosphoinositides) as a
recent large-scale CNV study of > 1600 individuals identi-
fied a paternally inherited duplication in two unrelated in-
dividuals with ASC that disrupts several exons of DAPP1
[96], and large duplications and deletions in the gene are
reported in the DECHIPER database—the majority of
which list autism, autistic behaviours, global developmen-
tal delay and/or intellectual disability as the associated
phenotype [97].
In the wider context of ASC research, immune system
disruption is one of the most consistent findings, with
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epidemiological studies showing that families with ASC-
affected individuals have a higher rate of autoimmune
disorders [98, 99], serological studies finding evidence of
increased numbers of activated B and NK cells [90] and
elevated levels of pro-inflammatory cytokines [100] in
peripheral blood samples and post-mortem studies find-
ing evidence of microglial activation in the dorsolateral
prefrontal cortex [101]. In addition, there is also a poten-
tial causal link between established environmental risk
factors such as prenatal viral infection and paternal age,
with immune dysregulation and inflammation and
increased risk of developmental disorders. In the case of
viral infection, animal studies have linked maternal
influenza infection to altered brain development and be-
haviour in mouse models of ASC and schizophrenia
[102, 103]. As for older paternal age, it has been sug-
gested that the observed increased incidence of ASC,
schizophrenia and bipolar disorder could be the result of
immune dysregulation [104] with increases in pro-
inflammatory cytokines IL-1β and IL-6 observed in all
three disorders [105, 106]. The accumulated evidence
from these diverse studies and the potential link to en-
vironmental factors makes a compelling case for priori-
tising the immune-related genes identified here for
further study, where we might begin to investigate links
to specific environmental exposures. Future studies
should be designed in order to establish the molecular
drivers, look at the underlying mechanisms, ascertain
whether it is primary or secondary to ASC and whether
such immune markers might have utility for prognosis,
diagnosis or endophenotype classification.
Strengths and limitations
We used a population-based cohort of 10,000 twins
[50] to identify a rare sample of MZ twins discordant
for ASC, with the primary aim of identifying biological
differences free from genetic confounding. There are a
number of drawbacks and limitations with the ap-
proach taken. Firstly, as MZ twins stably discordant for
ASC are rare, the sample size was constrained. Whilst
sample sizes required for 80% power using disease-
discordant MZ twins is ~ 15% smaller than case-control
designs, based on published EWAS power simulations
our N of 40 would not be powered to detect small
methylation differences at p < 1 × 10−6 [107, 108]. While
replication using larger sample sizes is required, this
study gives an indication of the value of the discordant-
twin design and integrative approach for identifying
modest biological signals.
Next, there is the use of peripheral blood for expres-
sion profiling, since the relationship between individual
differences in gene expression in blood and brain is not
yet fully understood. Whilst considerable similarities be-
tween RNA transcription in blood and brain have been
reported for subsets of genes, it is not a prerequisite that
peripheral gene expression exactly resembles that of the
brain—only that it is a reliable marker of disease and is
informative about underlying biological mechanisms
[109, 110]. Peripheral blood also offers several important
advantages over post-mortem brain tissue such as avail-
ability (especially at developmentally relevant time
points), control of tissue quality and handling and col-
lection of relevant donor characteristics.
There is the issue of age of the participants at sample
collections, since these were collected during adolescence.
ASC is a disorder of development and so it is not known
whether the molecular differences identified would reflect
those present in early development, or whether they are
primary or secondary to onset. While the current study is
not able to address developmental questions related to on-
set and trajectory, future genomic studies using prospect-
ive birth cohorts containing infants at risk of ASC will be
highly valuable in this regard.
One assumption of this study is that that MZ twins are
genetically identical. MZ twins have been found to display
rare genetic differences, for example point mutations, copy
number variants, telomere length, uniparental disomy,
somatic mosaicism, chromosomal aneuploidies and muta-
tions in mitochondrial DNA (see [32] for a discussion of
these issues). Without comprehensive DNA sequence data
on the individuals, the possibility that the observed pheno-
typic discordances are the result of post-twinning de novo
mutations cannot be ruled out. However, this is not likely
as whole-genome sequencing and SNP microarray-based
studies have failed to find many replicable differences be-
tween MZ twins [32, 111], and there have been few reports
of discordant MZ twins having a DNA sequence mutation
causative for a disease [112].
The integrative analysis performed combining RNA-seq
and DNA methylation data on the same individuals was
limited in its scope, due to use of low-resolution methyla-
tion data from the Illumina 27 K array and absence of gen-
omic data on the same individuals. Therefore, a basic
integrative analysis was performed summarising DNA
methylation signals at the gene-level, and limiting to iden-
tification of cis regulatory signals—since the sites covered
on the array would be expected to mainly fall in to this
category. We opted for evidence in combination and did
not perform causal inference, due to the lack of DNA
sequence data which is typically used to help establish dir-
ectionality between the intermediate traits and phenotype.
Our top-ranked (FDR < 10%) DE genes do not show
evidence of differential methylation in our 27k dataset, but
we cannot rule out the role of other cis regulatory mecha-
nisms such as histone tail modifications, non-coding
RNAs or trans effects. That said, it is encouraging that
genes previously associated with ASC showed combined
evidence for dysregulation across our gene expression and
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DNA methylation datasets, and given the limitations of
the strategy used, we consider this primarily a useful
demonstration of the potential utility of combining a
twin-based study design with multi-omics datasets. In
future studies, should genotype data and higher resolution
methylation data on the same individuals become avail-
able, a more comprehensive, genome-wide, site-level
eQTM scan could be performed in combination with
causal analysis methods to determine the likely
relationship between genotype, expression, methylation,
and trait [113].
Finally, the current study focused on gene-level ex-
pression but the data generated could be utilised to in-
vestigate other transcriptomic phenomena such as
alternative splicing, allele-specific expression and ex-
pression of non-coding RNAs (e.g. lncRNA). Alterna-
tive splicing in particular is thought to play a critical
role in neuronal development, with some evidence that
it could be relevant to ASC pathology [114, 115]. There
are also examples of allele-specific gene expression
linked to ASC [116, 117].
Conclusions
We characterised gene expression in a cohort of discord-
ant and concordant ASC twin pairs using blood RNA-
seq. The results from the discordant twin analysis re-
vealed enrichment for immune system, transcriptional
control and cell cycle regulation pathways in the identi-
fied DE genes, which may represent downstream risk
pathways where non-shared environmental or stochastic
factors converge. We further incorporated DNA methy-
lation profiles on the same individuals and performed a
combined analysis to identify putative ASC associated
cis regulatory signals. While the integrative strategy was
limited in its scope, we believe it is a useful demonstra-
tion of the potential utility and power of the MZ twins
design combined with multi-omics integration for maxi-
mising the potential to identify disease-associated sig-
nals. We hope the RNA-seq dataset we have generated
here will serve as a valuable resource for future investi-
gations into the gene expression patterns underlying
ASC (including examination of alternative splicing,
allele-specific expression and expression of non-coding
RNAs), and work focused on untangling genetic and en-
vironmental risk pathways.
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